S&P 500   4,515.11 (+0.64%)
DOW   35,437.59 (+0.51%)
QQQ   374.56 (+0.51%)
AAPL   148.49 (+1.32%)
MSFT   308.15 (+0.28%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   869.99 (-0.01%)
AMZN   3,424.05 (-0.66%)
NVDA   223.16 (+0.42%)
BABA   173.55 (+4.03%)
NIO   40.09 (+1.21%)
CGC   13.51 (+2.35%)
GE   104.78 (+0.63%)
AMD   116.99 (+0.48%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.57 (+0.06%)
ACB   6.96 (+0.58%)
DIS   170.45 (-0.40%)
PFE   42.05 (+1.77%)
BA   216.14 (-0.39%)
AMC   42.68 (-0.81%)
S&P 500   4,515.11 (+0.64%)
DOW   35,437.59 (+0.51%)
QQQ   374.56 (+0.51%)
AAPL   148.49 (+1.32%)
MSFT   308.15 (+0.28%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   869.99 (-0.01%)
AMZN   3,424.05 (-0.66%)
NVDA   223.16 (+0.42%)
BABA   173.55 (+4.03%)
NIO   40.09 (+1.21%)
CGC   13.51 (+2.35%)
GE   104.78 (+0.63%)
AMD   116.99 (+0.48%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.57 (+0.06%)
ACB   6.96 (+0.58%)
DIS   170.45 (-0.40%)
PFE   42.05 (+1.77%)
BA   216.14 (-0.39%)
AMC   42.68 (-0.81%)
S&P 500   4,515.11 (+0.64%)
DOW   35,437.59 (+0.51%)
QQQ   374.56 (+0.51%)
AAPL   148.49 (+1.32%)
MSFT   308.15 (+0.28%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   869.99 (-0.01%)
AMZN   3,424.05 (-0.66%)
NVDA   223.16 (+0.42%)
BABA   173.55 (+4.03%)
NIO   40.09 (+1.21%)
CGC   13.51 (+2.35%)
GE   104.78 (+0.63%)
AMD   116.99 (+0.48%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.57 (+0.06%)
ACB   6.96 (+0.58%)
DIS   170.45 (-0.40%)
PFE   42.05 (+1.77%)
BA   216.14 (-0.39%)
AMC   42.68 (-0.81%)
S&P 500   4,515.11 (+0.64%)
DOW   35,437.59 (+0.51%)
QQQ   374.56 (+0.51%)
AAPL   148.49 (+1.32%)
MSFT   308.15 (+0.28%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   869.99 (-0.01%)
AMZN   3,424.05 (-0.66%)
NVDA   223.16 (+0.42%)
BABA   173.55 (+4.03%)
NIO   40.09 (+1.21%)
CGC   13.51 (+2.35%)
GE   104.78 (+0.63%)
AMD   116.99 (+0.48%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.57 (+0.06%)
ACB   6.96 (+0.58%)
DIS   170.45 (-0.40%)
PFE   42.05 (+1.77%)
BA   216.14 (-0.39%)
AMC   42.68 (-0.81%)
NYSE:ASPN

Aspen Aerogels Stock Forecast, Price & News

$48.93
-0.47 (-0.95 %)
(As of 10/19/2021 11:35 AM ET)
Add
Compare
Today's Range
$48.34
$48.93
50-Day Range
$34.11
$49.67
52-Week Range
$10.50
$51.57
Volume665 shs
Average Volume247,105 shs
Market Capitalization$1.61 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.5
30 days | 90 days | 365 days | Advanced Chart
Receive ASPN News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspen Aerogels and its competitors with MarketBeat's FREE daily newsletter.


Aspen Aerogels logo

About Aspen Aerogels

Aspen Aerogels, Inc. engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee on May 4, 2001 and is headquartered in Northborough, MA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Lumber & other construction materials
Sub-Industry
N/A
Employees
290
Year Founded
N/A

Sales & Book Value

Annual Sales
$100.27 million
Book Value
$2.53 per share

Profitability

Net Income
$-21.81 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$1.61 billion
Next Earnings Date
10/28/2021 (Confirmed)
Optionable
Not Optionable

MarketRank

Overall MarketRank

2.20 out of 5 stars

Construction Sector

63rd out of 136 stocks

Lumber & Other Construction Materials Industry

2nd out of 7 stocks

Analyst Opinion: 2.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -












Aspen Aerogels (NYSE:ASPN) Frequently Asked Questions

Is Aspen Aerogels a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspen Aerogels in the last twelve months. There are currently 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Aspen Aerogels stock.
View analyst ratings for Aspen Aerogels
or view top-rated stocks.

What stocks does MarketBeat like better than Aspen Aerogels?

Wall Street analysts have given Aspen Aerogels a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aspen Aerogels wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aspen Aerogels?

Aspen Aerogels saw a decrease in short interest in August. As of August 31st, there was short interest totaling 510,900 shares, a decrease of 28.7% from the August 15th total of 716,600 shares. Based on an average trading volume of 273,400 shares, the days-to-cover ratio is currently 1.9 days.
View Aspen Aerogels' Short Interest
.

When is Aspen Aerogels' next earnings date?

Aspen Aerogels is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for Aspen Aerogels
.

How can I listen to Aspen Aerogels' earnings call?

Aspen Aerogels will be holding an earnings conference call on Thursday, October 28th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Aspen Aerogels' earnings last quarter?

Aspen Aerogels, Inc. (NYSE:ASPN) issued its quarterly earnings data on Wednesday, July, 28th. The construction company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.04. The construction company earned $31.67 million during the quarter, compared to analyst estimates of $25.35 million. Aspen Aerogels had a negative trailing twelve-month return on equity of 30.20% and a negative net margin of 24.17%.
View Aspen Aerogels' earnings history
.

How has Aspen Aerogels' stock been impacted by COVID-19?

Aspen Aerogels' stock was trading at $6.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ASPN shares have increased by 648.8% and is now trading at $48.67.
View which stocks have been most impacted by COVID-19
.

What guidance has Aspen Aerogels issued on next quarter's earnings?

Aspen Aerogels issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share (EPS) guidance of $-1.040-$-0.940 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-1.010. The company issued revenue guidance of $110 million-$118 million, compared to the consensus revenue estimate of $109.37 million.

What price target have analysts set for ASPN?

9 equities research analysts have issued 1-year price targets for Aspen Aerogels' stock. Their forecasts range from $8.00 to $58.00. On average, they anticipate Aspen Aerogels' stock price to reach $41.85 in the next year. This suggests that the stock has a possible downside of 14.0%.
View analysts' price targets for Aspen Aerogels
or view top-rated stocks among Wall Street analysts.

Who are Aspen Aerogels' key executives?

Aspen Aerogels' management team includes the following people:
  • Donald R. Young, President, Chief Executive Officer & Director
  • Gregg R. Landes, Senior VP-Operations & Strategic Development
  • John F. Fairbanks, Chief Financial Officer, Treasurer & VP
  • George L. Gould, Chief Technology Officer
  • Corby C. Whitaker, Senior Vice President-Sales & Marketing

What is Donald R. Young's approval rating as Aspen Aerogels' CEO?

5 employees have rated Aspen Aerogels CEO Donald R. Young on Glassdoor.com. Donald R. Young has an approval rating of 100% among Aspen Aerogels' employees. This puts Donald R. Young in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Aspen Aerogels' key competitors?

What other stocks do shareholders of Aspen Aerogels own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspen Aerogels investors own include Intelsat (I), Gilead Sciences (GILD), Bank of America (BAC), AMC Entertainment (AMC), Fossil Group (FOSL), Associated British Foods (ABF), Apollo Global Management (APO), Chaarat Gold (CGH), China Unicom (Hong Kong) (CHU) and Ciena (CIEN).

What is Aspen Aerogels' stock symbol?

Aspen Aerogels trades on the New York Stock Exchange (NYSE) under the ticker symbol "ASPN."

Who are Aspen Aerogels' major shareholders?

Aspen Aerogels' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Roubaix Capital LLC (0.24%). Company insiders that own Aspen Aerogels stock include Corby C Whitaker and Kelley Conte.
View institutional ownership trends for Aspen Aerogels
.

Which institutional investors are selling Aspen Aerogels stock?

ASPN stock was sold by a variety of institutional investors in the last quarter, including Roubaix Capital LLC. Company insiders that have sold Aspen Aerogels company stock in the last year include Corby C Whitaker, and Kelley Conte.
View insider buying and selling activity for Aspen Aerogels
or view top insider-selling stocks.

How do I buy shares of Aspen Aerogels?

Shares of ASPN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aspen Aerogels' stock price today?

One share of ASPN stock can currently be purchased for approximately $48.67.

How much money does Aspen Aerogels make?

Aspen Aerogels has a market capitalization of $1.60 billion and generates $100.27 million in revenue each year. The construction company earns $-21.81 million in net income (profit) each year or ($0.83) on an earnings per share basis.

How many employees does Aspen Aerogels have?

Aspen Aerogels employs 290 workers across the globe.

What is Aspen Aerogels' official website?

The official website for Aspen Aerogels is www.aerogel.com.

Where are Aspen Aerogels' headquarters?

Aspen Aerogels is headquartered at 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532.

How can I contact Aspen Aerogels?

Aspen Aerogels' mailing address is 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532. The construction company can be reached via phone at (508) 691-1111 or via email at [email protected].


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.